New potential treatment for aggressive brain cancer in children

Using state-of-the-art gene editing technology, scientists from Ann & Robert H. Lurie Children's Hospital of Chicago have discovered a promising target to treat atypical teratoid/rhabdoid tumor (AT/RT) - a highly aggressive and therapy resistant brain tumor that mostly occurs in infants.

Read more: https://www.eurekalert.org/pub_releases/2017-04/arh-npt041117.php